Zhuhui Rong

Dr. Zhuhui Rong


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2020 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
WLWei Liu
Wei Liu
JWJing Wang
Jing Wang
WLWenbin Li
Wenbin Li
ZZZhaoxian Zhou
Zhaoxian Zhou
SLSiying Liu
Siying Liu
ZRZhuhui Rong
Zhuhui Rong

1 May 2016 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
ZRZhuhui Rong
Zhuhui Rong
WLWen-Bin Li
Wen-Bin Li
WLWei Liu
Wei Liu
BCBao-Huan Cai
Bao-Huan Cai
JWJing Wang
Jing Wang
LCLi-Wen Chang
Li-Wen Chang

21 October 2020 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ZRZhuhui Rong
Zhuhui Rong
LMLuxia Mo
Luxia Mo
RPRui Pan
Rui Pan
XZXiaofang Zhu
Xiaofang Zhu
HCHongbin Cheng
Hongbin Cheng
LCLiwen Chang
Liwen Chang
Neonatal acute respiratory distress syndrome (NARDS) reflects pulmonary surfactant dysfunction, and the usage of bovine surfactant (Calsurf) supplement may therefore be beneficial. To determine whether bovine surfactant given in NARDS can improve oxygenation and survival rate, we conducted a multicenter, randomized trial between January 2018 and June 2019, and we compared Calsurf treatment to controls in neonates with pneumonia accompanied by NARDS. Neonates who met the Montreux criteria definition of NARDS were included, and those with congenital heart and lung malformations were excluded. Primary outcomes were oxygenation index (OI) after Calsurf administration, and secondary outcomes were mortality, and duration of ventilator and oxygen between the two groups, and also other morbidities. Cumulatively, 328 neonates were recruited and analyzed, 162 in the control group, and 166 in the Calsurf group. The results shows that OI in the Calsurf group were significantly lower than that in the control group at 4 h (7.2 ± 2.7 and 11.4 ± 9.1, P = 0.001); similarly, OI in the Calsurf group were significantly lower than in the control group at 12 h ( 7.5 ± 3.1 and 11.2 ± 9.2, P = 0.001). Mortality and duration of ventilator support or oxygen use between the two groups were not significantly different. Conclusion: Calsurf acutely improved OI immediately after administration in pneumonia-induced NARDS; although, we observed no significant decrease in mortality, duration of ventilator or oxygen, or major morbidity. What is known: • The definition proposed as the Monteux criteria for neonatal acute respiratory distress syndrome (NARDS). • Surfactant acutely improved oxygenation and significantly decreased mortality in children and adolescents with acute lung injury. What is new: • This is the first large randomized controlled trail to study on surfactant treatment of neonates with acute respiratory distress syndromes. • Surfactant acutely improved oxygenation immediately after administration in pneumonia-induced NARDS at a gestational age beyond 34 weeks

6 September 2020 in American Journal of Perinatology
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
HCHongbin Cheng
Hongbin Cheng
JWJing Wang
Jing Wang
LDLingli Ding
Lingli Ding
ZZZhaoxian Zhou
Zhaoxian Zhou
ZRZhuhui Rong
Zhuhui Rong
Objective The perinatal consequences of neonates born to severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) infected mothers are uncertain. This study aimed to compare the differences in clinical manifestation, laboratory results, and outcomes of neonates born to mothers with or without coronavirus disease 2019 (COVID-19). Study Design A total of 48 neonates were admitted to Tongji Hospital and HuangShi Maternal and Child Healthcare Hospital from January 17 to March 4, 2020. The neonates were divided into three groups according to the mothers' conditions: neonates born to mothers with confirmed COVID-19, neonates born to mothers with clinically diagnosed COVID-19, and neonates born to mothers without COVID-19. The clinical data of mothers and infants in the three groups were collected, compared, and analyzed. Results The deliveries occurred in a negative pressure isolation room, and the neonates were separated from their mothers immediately after birth for further observation and treatment. None of the neonates showed any signs of fever, cough, dyspnea, or diarrhea. SARS-CoV-2 reverse transcriptase-polymerase chain reaction of the throat swab and feces samples from the neonates in all three groups was negative. No differences were detected in the whole blood cell, lymphocytes, platelet, and liver and renal function among the three groups. All mothers and their infants showed satisfactory outcomes, including a 28-week preterm infant. Conclusion The clinical manifestations, radiological, and biochemical results did not show any difference between the three groups. No evidence of vertical transmission was found in this study whether the pregnant women developed coronavirus infection in the third (14 cases) or second trimester (1 case). Key points * These authors contributed equally to this work and shall be considered co-first authors. Received: 19 June 2020 Accepted: 07 August 2020 Publication Date: 06 September 2020 (online) © . Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

15 June 2021 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
RPRui Pan
Rui Pan
GCGao-Yan Chen
Gao-Yan Chen
JWJing Wang
Jing Wang
ZZZhao-Xian Zhou
Zhao-Xian Zhou
PZPing-Ying Zhang
Ping-Ying Zhang
ZRZhuhui Rong
Zhuhui Rong

1 March 2006 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
WLWenbin Li
Wenbin Li
CLChang Liwen
Chang Liwen
ZRZhuhui Rong
Zhuhui Rong
ZQZhang Qianshen
Zhang Qianshen
WHWang Hua
Wang Hua
WLWei Liu
Wei Liu